Blended collaborative care in the secondary prevention of coronary heart disease improves risk factor control: Results of a randomised feasibility study.


Journal

European journal of cardiovascular nursing
ISSN: 1873-1953
Titre abrégé: Eur J Cardiovasc Nurs
Pays: England
ID NLM: 101128793

Informations de publication

Date de publication:
02 2020
Historique:
pubmed: 1 10 2019
medline: 2 2 2021
entrez: 1 10 2019
Statut: ppublish

Résumé

Risk factor control is essential in limiting the progression of coronary heart disease, but the necessary active patient involvement is often difficult to realise, especially in patients suffering psychosocial risk factors (e.g. distress). Blended collaborative care has been shown as an effective treatment addition, in which a (non-physician) care manager supports patients in implementing and sustaining lifestyle changes, follows-up on patients, and integrates care across providers, targeting both, somatic and psychosocial risk factors. The aim of this study was to test the feasibility, acceptance and effect of a six-month blended collaborative care intervention in Germany. For our randomised controlled pilot study with a crossover design we recruited coronary heart disease patients with ⩾1 insufficiently controlled cardiac risk factors and randomised them to either immediate blended collaborative care intervention (immediate intervention group, Participation rate in the intervention phase was 67% ( This study shows that blended collaborative care can be a feasible, accepted and effective addition to standard medical care in the secondary prevention of coronary heart disease in the German healthcare system.

Sections du résumé

BACKGROUND
Risk factor control is essential in limiting the progression of coronary heart disease, but the necessary active patient involvement is often difficult to realise, especially in patients suffering psychosocial risk factors (e.g. distress). Blended collaborative care has been shown as an effective treatment addition, in which a (non-physician) care manager supports patients in implementing and sustaining lifestyle changes, follows-up on patients, and integrates care across providers, targeting both, somatic and psychosocial risk factors.
AIMS
The aim of this study was to test the feasibility, acceptance and effect of a six-month blended collaborative care intervention in Germany.
METHODS
For our randomised controlled pilot study with a crossover design we recruited coronary heart disease patients with ⩾1 insufficiently controlled cardiac risk factors and randomised them to either immediate blended collaborative care intervention (immediate intervention group,
RESULTS
Participation rate in the intervention phase was 67% (
CONCLUSION
This study shows that blended collaborative care can be a feasible, accepted and effective addition to standard medical care in the secondary prevention of coronary heart disease in the German healthcare system.

Identifiants

pubmed: 31564125
doi: 10.1177/1474515119880062
doi:

Banques de données

ClinicalTrials.gov
['NCT02389153']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

134-141

Auteurs

Lena Bosselmann (L)

Department of Psychosomatic Medicine and Psychotherapy, University of Göttingen Medical Center, Germany.

Stella V Fangauf (SV)

Department of Psychosomatic Medicine and Psychotherapy, University of Göttingen Medical Center, Germany.
German Center for Cardiovascular Research (DZHK), Germany.

Birgit Herbeck Belnap (B)

Department of Psychosomatic Medicine and Psychotherapy, University of Göttingen Medical Center, Germany.
Center for Behavioral Health and Smart Technology, University of Pittsburgh School of Medicine, USA.

Mira-Lynn Chavanon (ML)

Faculty of Psychology, Philipps-University Marburg, Germany.

Jonas Nagel (J)

Department of Psychosomatic Medicine and Psychotherapy, University of Göttingen Medical Center, Germany.
German Center for Cardiovascular Research (DZHK), Germany.

Claudia Neitzel (C)

Department of Psychosomatic Medicine and Psychotherapy, University of Göttingen Medical Center, Germany.

Anna Schertz (A)

Department of Psychosomatic Medicine and Psychotherapy, University of Göttingen Medical Center, Germany.

Eva Hummers (E)

Department of General Practice, University of Göttingen Medical Center, Germany.

Rolf Wachter (R)

German Center for Cardiovascular Research (DZHK), Germany.
Clinic and Policlinic for Cardiology, University Hospital Leipzig, Germany.

Christoph Herrmann-Lingen (C)

Department of Psychosomatic Medicine and Psychotherapy, University of Göttingen Medical Center, Germany.
German Center for Cardiovascular Research (DZHK), Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH